Pathyaപഥ്യം
← New record

IndiPGx-Read H-r01

Lab reportcohort · demo

10/30/2026, 6:27:17 AM · PharmCAT 3.4.0 · Research record, not medical advice

4
Genes standardised
4
Calls quoted
0
Coverage gaps
1
Identifiers removed
32.4s
Upload to record
  1. Muse Sparkread 4 gene calls19.8s
  2. PharmCATstandardised 4 genes12.6s
  3. Rules0 coverage gaps

CallsMuse Spark each call quoted from the source, then standardised by PharmCAT

Sample Molecular Diagnostics, Bengaluru - NOT A REAL LAB · 2 Oct 2026 · open original photo

Uploaded lab report photo
GeneAs printedStandardisedPhenotype term
CYP2C19“CYP2C19 rs4244285 G/G Wild type; CYP2C19 rs4986893 G/G Wild type; CYP2C19 rs12248560 C/C Wild type”*1/*1Normal Metabolizer
DPYD“DPYD rs75017182 C/G Heterozygous; DPYD rs1801265 A/A Wild type; DPYD rs3918290 C/C Wild type; DPYD rs55886062 A/A Wild type; DPYD rs67376798 T/T Wild type”Reference/c.1129-5923C>G, c.1236G>A (HapB3)Intermediate Metabolizer · activity 1.5
NUDT15“NUDT15 rs116855232 C/T Heterozygous”*1/*3Intermediate Metabolizer
UGT1A1“UGT1A1 rs3064744 (TA)6/(TA)7 Heterozygous; UGT1A1 rs4148323 G/A Heterozygous”*28/*6Poor Metabolizer

Method as printed: Method: targeted genotyping by real-time PCR. Only the listed variants are assayed; variants outside this panel cannot be excluded. Genotypes are reported per rsID on the forward strand. Star-allele assignment is left to the treating clinician.

Coveragedeterministic rules · which India-relevant variants this panel named

DPYDHapB3named on the report

Most common Indian decreased-function DPYD variant (~3.3%, PMID 40810747)

DPYDc.85T>C (*9A)named on the report

~25% in Indians; toxicity signal in South Indian cohorts (PMC11300675)

DPYD*2Anamed on the report

European tier-1 variant; rare in Indians (PMID 40810747)

DPYD*13named on the report

Tier-1 no-function variant (PMID 39032821)

DPYDc.2846A>Tnamed on the report

Tier-1 variant; near-absent in Indians (PMID 40810747)

NUDT15*3named on the report

Main NUDT15 risk allele, ~7-11% in Indians (PMID 29470173)

UGT1A1*28named on the report

TA-repeat allele, common in South Asians

UGT1A1*6named on the report

East Asian allele; reported at low frequency in India

CYP2C19*2named on the report

Common no-function allele in South Asians

CYP2C19*17named on the report

Increased-function allele

A variant the panel did not name is left out of cohort statistics for that variant, rather than counted as absent. A patient or lab reference printed on the report was removed before storage. Reader notes: Only the listed variants are assayed; variants outside this panel cannot be excluded. CYP2C19 *1/*1 based on rs4244285, rs4986893, rs12248560 only; untested variants cannot be excluded. Star-allele assignment is left to the treating clinician per report.

Exportde-identified · the same record in three formats

Curator review

This is a read-only sample. In the pilot, a curator checks each call against the source document before the record counts in a cohort, and Muse Spark web search finds published Indian frequency data for each variant. Both are written to the audit log.

Sign in with the pilot code
Research tool, not medical advice. Pathya reads and standardises pharmacogenomic results; it makes no dose, drug or test recommendation. Audit log: data/cases/fd235f82cb0c/audit.log.